Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. grew its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 127.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 64,311 shares of the company's stock after acquiring an additional 36,071 shares during the period. Harbor Capital Advisors Inc. owned about 0.36% of Addus HomeCare worth $8,555,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company's stock valued at $131,910,000 after purchasing an additional 19,027 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after buying an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock worth $82,930,000 after acquiring an additional 5,421 shares during the period. Principal Financial Group Inc. raised its position in Addus HomeCare by 20.9% in the second quarter. Principal Financial Group Inc. now owns 430,444 shares of the company's stock worth $49,979,000 after acquiring an additional 74,488 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company's stock valued at $36,739,000 after acquiring an additional 254,705 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ADUS shares. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 price target on the stock. Stephens reaffirmed an "overweight" rating and issued a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Finally, StockNews.com cut Addus HomeCare from a "strong-buy" rating to a "buy" rating in a report on Sunday, July 7th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $131.38.

Addus HomeCare Trading Up 1.5 %

Shares of NASDAQ ADUS traded up $1.85 during trading on Friday, reaching $126.27. The company had a trading volume of 146,545 shares, compared to its average volume of 106,749. Addus HomeCare Co. has a twelve month low of $80.68 and a twelve month high of $136.12. The stock has a 50-day moving average price of $130.02 and a two-hundred day moving average price of $120.27. The stock has a market capitalization of $2.29 billion, a PE ratio of 29.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. During the same quarter in the previous year, the company posted $0.94 EPS. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.57 EPS for the current year.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company's stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 over the last quarter. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.